Viewing Study NCT04522167


Ignite Creation Date: 2025-12-25 @ 12:34 AM
Ignite Modification Date: 2025-12-25 @ 10:43 PM
Study NCT ID: NCT04522167
Status: COMPLETED
Last Update Posted: 2025-11-13
First Post: 2020-08-11
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Efficacy and Safety of the Aflibercept FYB203 Biosimilar in Comparison to Eylea® in Patients With Neovascular Age-Related Macular Degeneration
Sponsor: Bioeq GmbH
Organization: